BackgroundPrimaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivax endemic area in Mauritania.Methodology/principal findingsVenous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants...
International audienceABSTRACT. 8-Aminoquinoline antimalarial drugs (primaquine, tafenoquine) are re...
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD; EC 1.1.1.49) deficiency is one of the m...
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defe...
International audienceBackgroundPrimaquine is recommended by the World Health Organization (WHO) for...
Plasmodium vivax malaria is endemic in Mauritania. Individuals with glucose-6-phosphate dehydrogenas...
International audienceAbstract Background The elimination of Plasmodium vivax malaria requires 8-ami...
BackgroundG6PD enzyme deficiency is a common enzymatic X-linked disorder. Deficiency of the G6PD enz...
BACKGROUND: The study aimed to gain first data on the prevalence of G6PD enzyme deficiency measured ...
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is commonly seen in malaria endemic areas as it ...
Mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in red blood cells with increa...
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is common in populations liv...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and affec...
International audienceABSTRACT. 8-Aminoquinoline antimalarial drugs (primaquine, tafenoquine) are re...
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD; EC 1.1.1.49) deficiency is one of the m...
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defe...
International audienceBackgroundPrimaquine is recommended by the World Health Organization (WHO) for...
Plasmodium vivax malaria is endemic in Mauritania. Individuals with glucose-6-phosphate dehydrogenas...
International audienceAbstract Background The elimination of Plasmodium vivax malaria requires 8-ami...
BackgroundG6PD enzyme deficiency is a common enzymatic X-linked disorder. Deficiency of the G6PD enz...
BACKGROUND: The study aimed to gain first data on the prevalence of G6PD enzyme deficiency measured ...
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is commonly seen in malaria endemic areas as it ...
Mutations in the glucose-6-phosphate dehydrogenase (G6PD) gene result in red blood cells with increa...
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is common in populations liv...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and affec...
International audienceABSTRACT. 8-Aminoquinoline antimalarial drugs (primaquine, tafenoquine) are re...
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD; EC 1.1.1.49) deficiency is one of the m...
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defe...